Cartana
BIOTECH [...]
BIOTECH [...]
Top research is based on teamwork, with success derived from continually querying results. Pär Nordlund likens the work of a research director to the job of forming a talented corporate team.
Many years’ research has led Mats Wahlgren to a possible first drug treatment for acute manifestations of sickle cell anemia - a genetic condition that affects millions of people.
Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.
Aerocrine developed the world’s first nitrogen monoxide test for asthma sufferers. Today, the product is used around the globe to monitor asthma symptoms and adjust medication accordingly.
In Sweden, there are currently some 21,000 volunteers ready to respond to help cardiac arrest victims. A smartphone alert system guides them directly to victims – often faster than ambulances. The service, the result of research carried out at the Centrum för Hjärtstoppsforskning, is now ready for export markets.
Professor Hans von Holst is in his element where different disciplines intersect – where medicine meets technology. This is where his ideas have helped create, amongst other breakthroughs, MIPS, a technology that improves the protective properties of everyday helmets. Since 2011, the company has delivered around nine million helmets worldwide.
Children who exercise their working memory also find it easier to concentrate. This was one of the key insights that Torkel Klingberg gained from developing a clinical training programme for children with ADHD. The next step is a research-based tool to increase knowledge of mathematics among the world’s children.
The eye movement of a child reading may indicate an increased risk of dyslexia or reading difficulties. This discovery led to the formation of the company Lexplore that today has operations in Sweden, the UK and the US. Now, the researchers behind the breakthrough are adapting the technology to identify early Alzheimer’s and Parkinson’s.
Approximately five million cancer patients have received optimised radiotherapy with the help of RaySearch Laboratories. Today, the company is a global player, offering a management system that optimises the running of entire cancer clinics. And it all started with a Master’s thesis at Karolinska Institutet.